Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients With Sepsis

Crit Care Med. 2022 Jun 1;50(6):1018-1020. doi: 10.1097/CCM.0000000000005480. Epub 2022 May 19.

Authors

Teresa Vezza¹, Víctor M Víctor^{1

2

3}

Affiliations

¹ Service of Endocrinology and Nutrition, University Hospital Doctor Peset, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain.
² CIBERehd-Department of Pharmacology University of Valencia, Valencia, Spain.
³ Department of Physiology, University of Valencia, Valencia, Spain.

PMID: 35612442
DOI: 10.1097/CCM.0000000000005480

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diabetes Mellitus*
Humans
Hypoglycemic Agents / therapeutic use
Metformin* / therapeutic use
Protective Agents
Sepsis* / drug therapy

Substances

Hypoglycemic Agents
Protective Agents
Metformin